TY - JOUR T1 - Higher Physical Fitness Regulates <em>In Vitro</em> Tumor Cell Growth in Older Adults with Treatment Naïve Chronic Lymphocytic Leukemia (CLL) JF - medRxiv DO - 10.1101/2021.03.01.21252293 SP - 2021.03.01.21252293 AU - Andrea Sitlinger AU - Michael A. Deal AU - Erwin Garcia AU - Dana K. Thompson AU - Tiffany Stewart AU - Grace A. MacDonald AU - Nicolas Devos AU - David Corcoran AU - Janet S. Staats AU - Jennifer Enzor AU - Kent J. Weinhold AU - Danielle M. Brander AU - J. Brice Weinberg AU - David B. Bartlett Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/03/02/2021.03.01.21252293.abstract N2 - Chronic lymphocytic leukemia (CLL) is associated with physical dysfunction and low overall fitness that predicts poor survival following commencement of treatment. However, it remains unknown whether higher fitness in CLL patients provides anti-oncogenic effects. We identified ten fit (CLL-FIT) and ten less fit (CLL-UNFIT) treatment-naïve CLL patients from 144 CLL patients who completed a set of physical fitness and performance tests. Patient plasma was used to determine its effects on in vitro 5-day growth/viability of three B-cell cell lines (OSU-CLL, Daudi and Farage). Plasma exosomal miRNA profiles, circulating lipids, lipoproteins, inflammation levels, and immune cell phenotypes were also assessed. CLL-FIT was associated with fewer viable OSU-CLL cells at Day 1 (p=0.003), Day 4 (p=0.001) and Day 5 (p=0.009). No differences between groups were observed for Daudi and Farage cells. Of 455 distinct exosomal miRNAs identified, 32 miRNAs were significantly different between groups. Of these, 14 miRNAs had ≤-1 or ≥1 log2 fold differences. CLL-FIT patients had 5 exosomal miRNAs with lower expression and 9 miRNAs with higher expression. CLL-FIT patients had higher HDL cholesterol, lower inflammation, and lower levels of triglyceride components (all p&lt;0.05). CLL-FIT patients had lower frequencies of low-differentiated NKG2+/CD158a/bneg (p=0.015 and p=0.014) and higher frequencies of NKG2Aneg/CD158b+ mature NK-cells (p=0.047). Absolute numbers of lymphocytes including CD19+/CD5+ CLL-cells were similar between groups (p=0.359). Higher physical fitness in CLL patients is associated with altered CLL-like cell line growth in vitro, and with altered circulating and cellular factors indicative of better immune functions and tumor control.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by a Duke Claude D. Pepper Older Americans Independence Center Pilot Study Award (National Institutes of Health, National Institute on Aging P30-AG028716), National Institutes of Health, National Heart, Lung, and Blood Institute T32 grant (T32HL007057), the Durham Veterans Affairs Medical Center Research Service, an American Society of Hematology Scholars Award, and the Duke University Center for AIDS Research NIH funded program (P30 AI 64518).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Duke University Medical Center Institutional Review Board.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets generated during the present study are not publicly available, owing to the risk of disclosure or deduction of private individual information, but they are available from the corresponding author on reasonable request.6MWT6-minute walk testBCAAbranch chain amino acidCBCcomplete blood countCDcluster of differentiationCLLChronic Lymphocytic LeukemiaCLL-IPIChronic Lymphocytic Leukemia – International Prognostic IndexDMSODimethyl sulfoxideDPBSDulbecco’s phosphate buffered salineEBVEpstein Barr VirusEDTAEthylenediaminetetraacetic acideVO2peakestimated peak volume of oxygen consumptionFBSfetal bovine serumFFAFree Fatty AcidsFMOflow minus oneHDLhigh-density lipoproteinICAM-1Intercellular Adhesion Molecule 1IFNinterferonIGHVimmunoglobulin heavy chain variable region genesILinterleukinIPAQIncidental and Planned Activity QuestionnaireKIRKiller immunoglobulin-like receptorLDLlow-density lipoproteinLP-IRLipoprotein Insulin Resistance IndexmiRNAmicro-RNANK-cellNatural Killer CellNKG2CD94/NK group 2 memberNMRnuclear magnetic resonanceOSU-CLLOhio State University-Chronic Lymphocytic LeukemiaPBMCperipheral blood mononuclear cellPIpropidium iodideRNAribonucleic acidRPMIRoswell Park Memorial InstituteSBASStanford Brief Activity SurveySPPBshort physical performance batterySTATSignal transducer and activator of transcriptionTGFβTransforming growth factor βTNFαtumor necrosis factor αTRLtriglyceride rich lipoproteinTRLPtriglyceride rich lipoprotein particleTUGtimed-up and goUMIUnique Molecular Indices ER -